CIBC World Market’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-15,499
| Closed | -$4.78M | – | 1379 |
|
2025
Q1 | $4.78M | Sell |
15,499
-9,819
| -39% | -$3.03M | 0.01% | 456 |
|
2024
Q4 | $8.93M | Buy |
25,318
+10,102
| +66% | +$3.56M | 0.02% | 328 |
|
2024
Q3 | $5.45M | Buy |
15,216
+10,158
| +201% | +$3.64M | 0.01% | 410 |
|
2024
Q2 | $1.61M | Buy |
+5,058
| New | +$1.61M | ﹤0.01% | 623 |
|
2022
Q3 | – | Sell |
-991
| Closed | -$234K | – | 1232 |
|
2022
Q2 | $234K | Buy |
+991
| New | +$234K | ﹤0.01% | 1026 |
|
2019
Q2 | – | Sell |
-15,201
| Closed | -$1.78M | – | 1160 |
|
2019
Q1 | $1.78M | Sell |
15,201
-82
| -0.5% | -$9.62K | 0.01% | 471 |
|
2018
Q4 | $1.66M | Sell |
15,283
-4,201
| -22% | -$457K | 0.01% | 449 |
|
2018
Q3 | $2.49M | Sell |
19,484
-1,905
| -9% | -$244K | 0.01% | 436 |
|
2018
Q2 | $2.42M | Buy |
21,389
+16,404
| +329% | +$1.86M | 0.01% | 410 |
|
2018
Q1 | $560K | Buy |
4,985
+3,549
| +247% | +$399K | ﹤0.01% | 774 |
|
2017
Q4 | $212K | Sell |
1,436
-2,313
| -62% | -$341K | ﹤0.01% | 704 |
|
2017
Q3 | $439K | Sell |
3,749
-17,149
| -82% | -$2.01M | ﹤0.01% | 516 |
|
2017
Q2 | $2.71M | Buy |
20,898
+14,447
| +224% | +$1.87M | 0.01% | 370 |
|
2017
Q1 | $873K | Sell |
6,451
-2,778
| -30% | -$376K | ﹤0.01% | 566 |
|
2016
Q4 | $1.32M | Buy |
9,229
+1,115
| +14% | +$160K | ﹤0.01% | 499 |
|
2016
Q3 | $958K | Buy |
8,114
+1,792
| +28% | +$212K | ﹤0.01% | 546 |
|
2016
Q2 | $670K | Buy |
6,322
+68
| +1% | +$7.21K | ﹤0.01% | 604 |
|
2016
Q1 | $697K | Sell |
6,254
-333
| -5% | -$37.1K | ﹤0.01% | 542 |
|
2015
Q4 | $1.03M | Buy |
+6,587
| New | +$1.03M | 0.01% | 477 |
|
2015
Q3 | – | Sell |
-14,655
| Closed | -$2.55M | – | 923 |
|
2015
Q2 | $2.55M | Sell |
14,655
-11,333
| -44% | -$1.97M | 0.01% | 292 |
|
2015
Q1 | $4.48M | Buy |
25,988
+23,580
| +979% | +$4.07M | 0.02% | 180 |
|
2014
Q4 | $312K | Buy |
2,408
+35
| +1% | +$4.54K | ﹤0.01% | 676 |
|
2014
Q3 | $305K | Buy |
+2,373
| New | +$305K | ﹤0.01% | 641 |
|